Healthcare Resource Utilization (HCRU), Costs, and Mortality in Relation to Select Immune-Related Adverse Events (iraes) and Line of Therapy (LOT) in Patients (pts) with Advanced or Metastatic Urothelial Cancer (UC) Treated with Immune Checkpoint Inhibitor (ICI) Monotherapy.
JOURNAL OF CLINICAL ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined